Ann: Path Forward For Resubmission of MOXDUO NDA , page-2

re: Ann: Path Forward For Resubmission of MOX... Excellent news.

Finally, clarity on the way forward. This explains the recent rush or 'feeding frenzy' (exactly the same term came to mind while watching the action yesterday Perspicacity, nice one) on QRX shares this week. Someone knew this announcement was coming and they got in early.

The upward trend should continue. Im looking at the depth in Comsec and a lot of the sell orders have been pulled after close. Thats happened to some degree each day this week but not to the extent i see now. The market response to this announcement could be very positive.

Two key dates for the market to focus on:
- Advisory Committee (AC) recommendation toward the end of Q2 and
- Final FDA decision in Q3.

The AC recommendation will serve as a very good proxy for MoxDuo's 'approvability'. Less than 5.5 months to wait.

Looking forward to the meeting.